用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
TEVA PHARMA [IL](11)
TEVA PHARMA [US](2)
RAFILOVICH MICHAL [IL](2)
INI SANTIAGO [IL](1)
CHEN KOBI [IL](1)
TEVA PHARMACEUTICALS USA INC F [US](1)
TEVA PHARMA [US](1)
DOLITZKY YEHUDIT [IL](1)
AVEZOV YOSEPH [IL](1)
SPIVAK DINA [IL](1)
专利信息
Translation Company
查询条件
展开筛选条件
[专利权人] 包含 'TEVA PHARMA [IL]'
[药品] 包含 'Rosiglitazone'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
尾页
共
11
条记录, 当前第1/2页。
公开号
公开日
申请号
申请日
1.
EP2270007A1
2011/1/5
EP20100177961
2006/5/9
专利标题
:2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
专利权人
:
TEVA PHARMA [IL]
;
The disclosure relates to a pharmaceutical composition comprising a granulate of a mixture of: a) rosiglitazone maleate;b) at least one pharmaceutically acceptable carrier;and c) less than 0.1% of the compound of the formula (I): based on the combined weight of the compound of the formula (I) and rosiglitazone maleate.
2.
US2010056583A1
2010/3/4
US20090583509
2009/8/21
专利标题
:Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation
专利权人
:
TEVA PHARMA [IL]
;
TEVA PHARMACEUTICALS USA INC F [US]
;
The present invention provides crystalline forms of Rosiglitazone hydrobromide, methods of their preparation, as well as pharmaceutical compositions comprising these crystalline forms.
3.
WO2010021745A2
2010/2/25
WO2009US04783
2009/8/21
专利标题
:POLYMORPHIC FORMS OF ROSIGLITAZONE HYDROBROMIDE AND PROCESSES FOR THEIR PREPARATION
专利权人
:
TEVA PHARMA [IL]
;
TEVA PHARMA [US]
;
KANSAL VINOD KUMAR [IN]
;
RANJAN HARISH [IN]
;
NAYAL SANJAY [IN]
;
RAFILOVICH MICHAL [IL]
;
The present invention provides crystalline forms of Rosiglitazone hydrobromide, methods of their preparation, as well as pharmaceutical compositions comprising these crystalline forms.
4.
CN101426789A
2009/5/6
CN20068054397
2006/5/9
专利标题
:2-n-(5-[[4-(2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
专利权人
:
TEVA PHARMA [IL]
;
5.
EP2016076A2
2009/1/21
EP20080713237
2008/1/22
专利标题
:POLYMORPHIC FORMS OF ROSIGLITAZONE HYDROBROMIDE AND PROCESSES FOR PREPARATION THEREOF
专利权人
:
TEVA PHARMA [IL]
;
6.
KR20090006841A
2009/1/15
KR20087026795
2008/10/31
专利标题
:2-N-{5-[[4-[2-(METHYL-2-PYRIDINYLAMINO) ETHOXY] PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE} BUTANEDIOIC ACID, METHODS OF PREPARATION AND COMPOSITIONS WITH ROSIGLITAZONE MALEATE
专利权人
:
TEVA PHARMA [IL]
;
Disclosed is an isolated compound of the formula (I) along with methods of detecting it and of minimizing it in improved pharmaceutical compositions of rosiglitazone maleate.
7.
MX2008014298A
2008/11/26
MX20080014298
2008/11/7
专利标题
:2-N-(5-[[4-(2-METHYL-2-PYRIDINYLAMINO) ETHOXY] PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE) BUTANEDIOIC ACID, METHODS OF PREPARATION AND COMPOSITIONS WITH ROSIGLITAZONE MALEATE.
专利权人
:
TEVA PHARMA [IL]
;
Disclosed is an isolated compound of the formula (I) along with methods of detecting it and of minimizing it in improved pharmaceutical compositions of rosiglitazone maleate.
8.
WO2008091624A2
2008/7/31
WO2008US00857
2008/1/22
专利标题
:POLYMORPHIC FORMS OF ROSIGLITAZONE HYDROBROMIDE AND PROCESSES FOR PREPARATION THEREOF
专利权人
:
TEVA PHARMA [IL]
;
TEVA PHARMA [US]
;
INI SANTIAGO [IL]
;
CHEN KOBI [IL]
;
RAFILOVICH MICHAL [IL]
;
The present invention presents crystal forms of Rosiglitazone hydrobromide, denominated Form I and Form II, methods of their preparation, as well as pharmaceutical compositions comprising these crystalline forms.
9.
WO2007130064A1
2007/11/15
WO2006US17994
2006/5/9
专利标题
:2-N-(5-[[4-(2-METHYL-2-PYRIDINYLAMINO) ETHOXY] PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE) BUTANEDIOIC ACID, METHODS OF PREPARATION AND COMPOSITIONS WITH ROSIGLITAZONE MALEATE
专利权人
:
TEVA PHARMA [IL]
;
TEVA PHARMA [US]
;
DOLITZKY YEHUDIT [IL]
;
AVEZOV YOSEPH [IL]
;
SPIVAK DINA [IL]
;
LEIBOVICI MINUTZA [IL]
;
SOLOMON BEN-ZION [IL]
;
Disclosed is an isolated compound of the formula (I) along with methods of detecting it and of minimizing it in improved pharmaceutical compositions of rosiglitazone maleate.
10.
CA2647829A1
2007/11/15
CA20062647829
2006/5/9
专利标题
:2-N-(5-[[4-(2-(METHYL-2-PYRIDINYLAMINO) ETHOXY] PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE) BUTANEDIOIC ACID, METHODS OF PREPARATION AND COMPOSITIONS WITH ROSIGLITAZONE MALEATE
专利权人
:
TEVA PHARMA [IL]
;
Disclosed is an isolated compound of the formula (I) along with methods of detecting it and of minimizing it in improved pharmaceutical compositions of rosiglitazone maleate.
首页
1
2
尾页
共
11
条记录, 当前第1/2页。
当前查询条件: [专利权人] 包含 'TEVA PHARMA [IL]'
AND
[药品] 包含 'Rosiglitazone'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文